5,820 trials (keyword fallback)
HIV Infections · Meningitis
Primary: Number of Immunogenic Responders, With Response Defined as a 4-fold or Greater Increase in Serum Bactericidal Antibody Titers From Study Entry to Week 28 After 2 Doses…
Haemophilus Influenza
Primary: Number of Participants With Solicited Adverse Reactions — 507; 480 Count of Participants
Bacterial Meningitis
Primary: Day 7 Mortality — 61; 64 Participants
Varicella · Measles · Mumps
Primary: Percentage of Participants Meeting Antibody Response Rate Criteria to Measles, Mumps, Rubella, and Varicella — 97.4; 96.3; 96.7; 98.6 Percentage of Participants
Haemophilus Influenzae Type B · Hepatitis B
Primary: The Number of Anti-HBs Seroprotected Participants 1 Month After the Third Dose. — 230; 226 Participants
Streptococcus Pneumoniae · Haemophilus Influenzae
Primary: Number of Subjects With Any Solicited Local and General Symptoms — 15; 16; 4; 10 Subjects
Infections, Streptococcal
Primary: Number of Subjects With a First Episode Reported of Bacterial Community Acquired Pneumoniae (B-CAP) — 240; 304 Subjects
Diphtheria · Pertussis · Tetanus
Primary: Immunogenicity - Seroprotection (Seroconversion for Pertussis) to Each Vaccine Component — 93.1; 99.2; 98.5; 93.1 percentage of subjects
Pneumonia
Primary: Diagnosis of Pneumonia — 40; 32; 4; 12 Participants
Cryptococcal Meningitis
Primary: Early Fungicidal Activity — 0.39; 0.28 log10 CFU/mL/day
Haemophilus Influenzae Type B Infection
Primary: Anti-PRP IgG Geometric Mean Concentration (GMC) — 0.40; 0.41 μg/mL — p=0.85
Rheumatoid Arthritis · Arthritis
Primary: Self-Efficacy Exercise — 6.1 units on a scale
Healthcare-associated Pneumonia (HCAP) · Hospital Acquired Pneumonia (HAP) · Ventilator Associated Pneumonia (VAP)
Primary: All-cause Mortality Rate at Day 14 — 12.4; 11.6 percentage of participants — p=0.0020
Pneumonia
Primary: Number of Patients With Modified Diagnosis Probability After Low Dose CT (LDCT) — 10; 3; 4; 34 Participants
Microbiota · Anti-bacterial Agents
Primary: Degree of Microbial Disruption: Number of Patients With Recovery of Bacterial Species Richness at 185 Days Post-antibiotics — 3; 3; 2; 3 Participants